Intracranial pressure (ICP) is an important parameter to monitor in several neuropathologies. However, because current clinically accepted methods are invasive, its monitoring is limited to patients in critical conditions. On the other hand, there are other less critical conditions for which ICP monitoring could still be useful; therefore, there is a need to develop non-invasive methods. We propose a new method to estimate ICP based on the analysis of the non-invasive measurement of pulsatile, microvascular cerebral blood flow with diffuse correlation spectroscopy. This is achieved by training a recurrent neural network using only the cerebral blood flow as the input. The method is validated using a 50% split sample method using the data from a proof-of-concept study. The study involved a population of infants ( n = 6) with external hydrocephalus (initially diagnosed as benign enlargement of subarachnoid spaces) as well as a population of adults ( n = 6) with traumatic brain injury. The algorithm was applied to each cohort individually to obtain a model and an ICP estimate. In both diverse cohorts, the non-invasive estimation of ICP was achieved with an accuracy of 0.9) and good concordance (Lin's concordance correlation coefficient >0.9) in comparison with standard clinical, invasive ICP monitoring. This preliminary work paves the way for further investigations of this tool for the non-invasive, bedside assessment of ICP.
Based on recent developments in both single-photon detectors and timing electronic circuits, we designed a compact and cost effective time-domain diffuse optical tomography system operated at 1 Hz acquisition rate, based on eight silicon photomultipliers and an 8-channel time-to-digital converter. The compact detectors are directly hosted on the probe in a circular arrangement around a single light injection fiber, so to maximize light harvesting. Tomography is achieved exploiting the depth sensitivity that is encoded in the arrival time of detected photons. The system performances were evaluated on simulations to assess possible the limitations arising from the use of a single injection point, and then on phantoms and in vivo to prove the eligibility of these technologies for diffuse optical tomography.
Anesthetic agents suppress the patient’s awareness by disrupting the neuronal activity and by preventing the formation of memories in a dose-dependent manner.1 This work focuses on the anesthetic effect of propofol, which is a non-barbiturate intravenous agent used commonly for the induction and maintenance of anesthesia and for sedation in critical care.2,3 Of particular interest, due to propofol effect on the central nervous system, propofol induces a decrease in cerebral metabolic rate of oxygen (),4,5 and therefore, a dose-dependent depression of cerebral blood flow (CBF) while maintaining the physiological coupling between the two.4,6–9
Both morphology (depth, location, and shape) and the wavelength-dependent optical properties of the underlying tissue affect the observed signals of diffuse optics (DO).1,2 These are often modeled to be homogeneous or as simplified layered signals when fitting them with a theoretical model to obtain the quantities of interest.3–8 This is done not because the researchers do not appreciate the complex relationship between the two, but rather because the details of that relationship are too complex to know and utilize for practical measurements. Nevertheless, some more advanced methods utilizing a large number of source–detector pairs to reconstruct tomographic images use the underlying tissue morphology derived from brain scans as a priori information.9–11 This comes at the cost of being less practical.
Benign external hydrocephalus (BEH) is a condition usually diagnosed during the first year of life in infants presenting with macrocephaly or a rapidly increasing head circumference (HC). Neuroradiological findings show enlarged subarachnoid spaces—specifically at the frontotemporal lobes— and normal or moderately enlarged ventricles.1,2 BEH is commonly considered a self-limiting condition that does not require any treatment, but some children may present temporary or permanent psychomotor delays.3–7 Fine, gross motor and attentional skills have been identified as the most compromised developmental areas in infants with BEH.7–10 Additional complications, such as an increased risk of subdural hematoma and hypotonia, have also been reported.4,11,12
Anemia is a common complication observed in critically ill patients admitted to the intensive care unit (ICU). In the ICU setting, anemia can result from severe bleeding after trauma, acute blood loss, or hemorrhage during surgery. In addition, it arises in non-bleeding but critically ill patients experiencing a rapid decrease in blood arterial total hemoglobin concentration (Hgb)1 (details about the terminology and acronyms used in this article in relation to hemoglobin concentration are reported in Appendix A). Typically, anemia is defined by low arterial oxy-hemoglobin concentration () in blood or low hematocrit (HCT) percentage ( to 10 g/dL2,3 and 30%,4 respectively) relative to normal values ( to 15 g/dL and 35% to 50%, respectively). This is quite common in the general ICU critically ill population within the first three days after admission.